Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

252 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of two dosages of canrenone as add-on therapy in hypertensive patients taking ace-inhibitors or angiotensin II receptor blockers and hydrochlorothiazide at maximum dosage in a randomized clinical trial: The ESCAPE-IT trial.
Derosa G, Maffioli P, D'Avino M, Sala C, Mugellini A, Vulpis V, Felis S, Guasti L, Sarzani R, Bestetti A, Vanasia M, Gaudio G; ESCAPE-IT Trial Investigators group. Derosa G, et al. Among authors: guasti l. Cardiovasc Ther. 2017 Feb;35(1):47-54. doi: 10.1111/1755-5922.12235. Cardiovasc Ther. 2017. PMID: 27860389 Free PMC article. Clinical Trial.
Proprotein convertase subtilisin/kexin type 9 inhibitors treatment in dyslipidemic patients: a real world prescription.
Derosa G, Maffioli P, D'Angelo A, Girola A, Colombo E, Fiorenza AM, Macias JJC, Sanchez CL, Raddino R, Pasini GF, Triggiani M, Maresca AM, Tandurella N, Guasti L. Derosa G, et al. Among authors: guasti l. J Cardiovasc Med (Hagerstown). 2022 Feb 1;23(2):91-97. doi: 10.2459/JCM.0000000000001237. J Cardiovasc Med (Hagerstown). 2022. PMID: 34690259
Ambulatory blood pressure parameters after canrenone addition to existing treatment regimens with maximum tolerated dose of angiotensin-converting enzyme inhibitors/angiotensin II type 1 receptor blockers plus hydrochlorothiazide in uncontrolled hypertensive patients.
Guasti L, Gaudio G, Lupi A, D'Avino M, Sala C, Mugellini A, Vulpis V, Felis S, Sarzani R, Vanasia M, Maffioli P, Derosa G. Guasti L, et al. Drug Des Devel Ther. 2017 Aug 4;11:2293-2300. doi: 10.2147/DDDT.S134826. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 28831241 Free PMC article. Clinical Trial.
Tirosine kinase inhibitors adverse events.
Campiotti L, Maresca A, Guasti L, Grandi AM. Campiotti L, et al. Among authors: guasti l. Oncologist. 2014 Mar;19(3):306-7. doi: 10.1634/theoncologist.2013-0397. Oncologist. 2014. PMID: 24643716 Free PMC article.
In vitro effects of Apixaban on 5 different cancer cell lines.
Guasti L, Squizzato A, Moretto P, Vigetti D, Ageno W, Dentali F, Maresca AM, Campiotti L, Grandi AM, Passi A. Guasti L, et al. PLoS One. 2017 Oct 12;12(10):e0185035. doi: 10.1371/journal.pone.0185035. eCollection 2017. PLoS One. 2017. PMID: 29023465 Free PMC article.
252 results